Publications by authors named "N S H Tien"

Targeted metabolomics and lipidomics are increasingly utilized in clinical research, providing quantitative and comprehensive assessments of metabolic profiles that underlie physiological and pathological mechanisms. These approaches enable the identification of critical metabolites and metabolic alterations essential for accurate diagnosis and precision treatment. Mass spectrometry, in combination with various separation techniques, offers a highly sensitive and specific platform for implementing targeted metabolomics and lipidomics in clinical settings.

View Article and Find Full Text PDF

Clinically heterogeneous spectrum and molecular phenotypes of inflammatory bowel disease (IBD) remain to be comprehensively elucidated. This exploratory multi-omics study investigated the serum molecular profiles of Crohn's disease (CD) and ulcerative colitis (UC), in association with elevated fecal calprotectin and disease activity states. The serum proteome, metabolome, and lipidome of 75 treated IBD patients were profiled.

View Article and Find Full Text PDF

Objective: Meropenem degradation poses a challenge to continuous infusion (CI) implementation. However, data about the impact of degradation on the probability of target attainment (PTA) of meropenem has been limited. This study evaluated the stability of meropenem brands and the consequence of in-bottle degradation on PTA in different environmental scenarios.

View Article and Find Full Text PDF

Shrimp acute hepatopancreatic necrosis disease (AHPND) is one of the most devastating diseases to impact the global shrimp farming industry, with a mortality rate of 70 %-100 %. The key virulence factors are a pair of Photorhabdus insect-related (Pir)-like toxins, PirA and PirB. In this study, by using an in vitro transcription and translation assay, we first confirmed that the quorum sensing transcriptional regulator AphB could trigger the expression of its downstream genes after binding to the AphB binding sequence in the promoter region of the pirA/pirB operon.

View Article and Find Full Text PDF
Article Synopsis
  • * A cohort of 4,606 individuals with schizophrenia was compared to another 4,606 without the disease, revealing that schizophrenia patients had a significantly higher risk of T2DM, especially those not treated with APs.
  • * The research suggests that while schizophrenia increases the risk of T2DM, APs may provide some protective effects; however, other unmeasured factors could also influence T2DM risk, pointing to a need for careful monitoring by healthcare providers.
View Article and Find Full Text PDF